159 related articles for article (PubMed ID: 6457754)
1. Pattern of degradation of human complement fragment, C3b.
Sim E; Wood AB; Hsiung LM; Sim RB
FEBS Lett; 1981 Sep; 132(1):55-60. PubMed ID: 6457754
[No Abstract] [Full Text] [Related]
2. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
3. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of factor I mediated cleavage of the third component of complement.
Davis AE; Harrison RA
Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
[No Abstract] [Full Text] [Related]
5. Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').
Nagasawa S; Stroud RM
Immunochemistry; 1977; 14(11-12):749-56. PubMed ID: 146022
[No Abstract] [Full Text] [Related]
6. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I.
Ekdahl KN; Nilsson UR; Nilsson B
J Immunol; 1990 Jun; 144(11):4269-74. PubMed ID: 2140392
[TBL] [Abstract][Full Text] [Related]
7. Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H.
Farries TC; Seya T; Harrison RA; Atkinson JP
Complement Inflamm; 1990; 7(1):30-41. PubMed ID: 2138950
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
9. Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.
Seya T; Nagasawa S
J Biochem; 1985 Jan; 97(1):373-82. PubMed ID: 3158646
[TBL] [Abstract][Full Text] [Related]
10. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
11. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
[TBL] [Abstract][Full Text] [Related]
15. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I.
Pangburn MK; Müller-Eberhard HJ
Biochemistry; 1983 Jan; 22(1):178-85. PubMed ID: 6219696
[No Abstract] [Full Text] [Related]
17. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of classical C5 convertase in the complement system by factor H.
Ito S; Tamura N
Immunology; 1983 Dec; 50(4):631-5. PubMed ID: 6228516
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
Meri S; Pangburn MK
Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
[TBL] [Abstract][Full Text] [Related]
20. Species specificity of recognition by the alternative pathway of complement.
Horstmann RD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
